NL Industries Inc. (NL) Insider Trading

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Mar 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Mar 2025

Mar 12, 2025

Get an email when NL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Mar 12, 2025	Kevin B Kramer Director	Bought 17 parts	6,500	$7.14 average	$46k	70%	Form 4
Mar 11, 2025	Bryan A. Hanley Senior VP and Treasurer	Bought	250	$6.78	$2k	25%	Form 4
Mar 11, 2025	Kevin B Kramer Director	Bought 8 parts	6,500	$6.59 average	$43k	228%	Form 4

Mar 12, 2025
Kevin B Kramer
Director · bought 6,500 at avg $7.14
$46k
70% of stake
Mar 11, 2025
Bryan A. Hanley
Senior VP and Treasurer · bought 250 at $6.78
$2k
25% of stake
Mar 11, 2025
Kevin B Kramer
Director · bought 6,500 at avg $6.59
$43k
228% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Industrial Inorganic Chemicals

LXFRLuxfer Holdings PLC

LXULsb Industries Inc.

MRMDMariMed Inc.

DAWNDay One Biopharmaceuticals, Inc.

IBRXImmunityBio, Inc.

BEAMBeam Therapeutics Inc.

NUVBNuvation Bio Inc.

FFFutureFuel Corp

Spot a number that looks wrong? Check it in NL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.